Arcutis Biotherapeutics
ARQT
$8.47
Share price
-1.40%
Change (1 day)
-38.44%
Change (1 year)
Categories
Arcutis Biotherapeutics (ARQT) - P/B ratio
P/B ratio as of April 2024 : 11.0
According to Arcutis Biotherapeutics's latest financial reports the company has a price-to-book ratio of 11.0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Arcutis Biotherapeutics - P/B ratio (from 2020 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.44 | -20.09% |
| 2022-12-31 | 4.30 | 22.78% |
| 2021-12-31 | 3.50 | -22.74% |
| 2020-12-31 | 4.54 | |
| 2019-12-31 | N/A | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.43 | -77.91% | 🇺🇸 USA |